AIDS 2026: High efficacy continues in open label extensions to lenacapavir phase 3 PrEP studies
21 July 2026. Related: Conference reports, HIV prevention and transmission.
Intl AIDS 26th Rio 2026
Featured AIDS 2026: Programme highlights to look out for
20 July 2026. Related: Special reports, Conference reports, Treatment access.